Effect of N-Butylscopolammonium Bromide and Metamizol Sodium on Heart Rate, Blood Pressure, and Echocardiographic Measurements in Warmblood Horses With Aortic and Mitral Valve Regurgitation.
Authors: Dufourni Alexander, Demeyere Marie, Vernemmen Ingrid, Van Steenkiste Glenn, Verhaeghe Lize-Maria, van Loon Gunther, Decloedt Annelies
Journal: Journal of veterinary internal medicine
Summary
# Editorial Summary: Pharmacological Challenge Testing in Equine Valvular Disease N-Butylscopolammonium bromide combined with metamizol sodium (NBBM) is commonly administered during cardiac examinations to induce tachycardia and hypertension, potentially amplifying subtle cardiac murmurs; however, its effects on measurable valvular regurgitation have not been systematically evaluated in horses with established valve disease. Dufourni and colleagues performed comprehensive echocardiographic assessments—including chamber dimensions, Doppler flow measurements, and subjective murmur grading—on 40 Warmblood horses (20 with aortic regurgitation [AR] and 20 with mitral regurgitation [MR]) at rest and following NBBM administration (0.2 mg/kg NBB plus 25 mg/kg metamizol sodium). The pharmacological challenge reduced atrial and ventricular dimensions whilst increasing aortic and pulmonary vessel diameters across both groups; notably, left ventricular end-diastolic diameter decreased only in AR cases. Both murmur intensity and regurgitant jet area increased significantly with challenge administration, rising in horses with AR and MR respectively. For practitioners performing serial cardiac evaluations, these findings emphasise that NBBM-induced changes in haemodynamics and chamber geometry directly alter the echocardiographic appearance of valvular insufficiency, meaning longitudinal comparisons of disease progression must account for whether measurements were obtained under resting or pharmacologically stimulated conditions to avoid misinterpreting genuine deterioration or improvement in valve function.
Read the full abstract on PubMed
Practical Takeaways
- •NBBM administration significantly accentuates cardiac murmurs and regurgitant jet size in horses with valve disease, which may confound clinical assessment during routine examinations—consider timing of medications relative to cardiac evaluations
- •The differential response between AR and MR horses (LV diameter changes) suggests valve-type-specific hemodynamic effects that should inform how you interpret echocardiographic changes during longitudinal monitoring
- •Heart rate and blood pressure changes from NBBM must be accounted for when comparing serial cardiac exams; standardize measurement conditions and consider avoiding this drug combination perioperatively in horses with known valvular disease
Key Findings
- •Pharmacological challenge with N-butylscopolammonium bromide and metamizol sodium increased cardiac murmur intensity in both AR and MR horses (p≤0.03)
- •Regurgitant jet area increased significantly during pharmacological challenge in both AR (p≤0.02) and MR (p=0.03) horses
- •Left ventricular end-diastolic diameter decreased during challenge in AR horses but not MR horses (p<0.02)
- •Atrial and ventricular dimensions decreased while aortic and pulmonary dimensions increased during pharmacological challenge (p≤0.02)